The moves boost the authority of Tim Hodge and Dimple Shah in Osaic's management structure.
The $140M advisor from Benjamin F. Edwards joins Raymond James Financial Services with around two decades of experience.
Why is this firm losing senior female executives, questions industry source.
Are firms hiding the price tag, or are clients simply not paying enough attention? Either way, these accounts are now on everyone's radar.
The advisory teams formerly with Lincoln Financial's wealth unit are uniting into a planning supergroup of more than 30 advisors.
The longtime Avantax president has been elevated to his new role as the broker-dealer giant looks ahead to its next growth phase.
"Highly leveraged wealth managers face the greatest competitive risk from an increase in rates paid to clients," according to Moody's.
"We're seeing more instances of clients being switched out of annuities," says one plaintiff's attorney.
"If they do something quickly to stabilize the firm they should be fine," one industry executive said about B. Riley Financial.
The broker-dealer giant is shuffling the leadership within Raymond James & Associates as part of its broader seismic reorganization.
The tax-focused Cetera subsidiary’s latest add in Northern California comes after overseeing $60M at LPL.
The Atlanta-based team originally with Lincoln Financial provides planning with a focus on retirement strategies for mass-affluent clients.
Broker-dealers are particularly interest rate sensitive companies.
The advisor "converted approximately $9,000 of chapter funds for his personal use," according to Finra.
The elite five-advisor team with a focus on HNW clients and retirement planning is extending the IBD giant’s recruitment streak in Texas
It's unusual for brokerage chiefs or senior officers to admit any shortcomings in their operations.
It's not clear why Jen Roche left Osaic.
The activity at Osaic comes as the wealth management market waits to see if an IPO is in the firm's future.
Meanwhile, Wells Fargo is attempting to close the books on the SEC's investigation.
GPB clients needed "that 8% to live and buy medicine," says one industry executive.
